In this article, you will discover the implementation of a collaboration program between students, startups, and large companies and the lessons we have learned.
On November 19th, 2020, as France is in the midst of preparing its Covid-19 vaccination campaign, AstraZeneca and Janssen called upon companies for the launch of projects to select startups that will participate in the Inno’Vaccins program, in partnership with DPD group, Ipsos and the Ipeps Paris-Salpêtrière incubator.
The objective is clear: to select 10 start-ups based on their abilities related to demand forecasting, accessibility, logistical organization, and the implementation of monitoring to combat any possible obstacles or disincentives for the national vaccination campaign.
The ambition of the collaboration between ESCP and AstraZeneca
Following this call for projects, the MsM (Specialized Master in Pharmaceutical and Biotechnology Management – ESCP) and AstraZeneca joined forces to select MsM students to work for several weeks with the startups selected in the Inno’Vaccins program.
Frédéric Jallat, Scientific Director of the MsM, established the following objectives for this full-scale project:
- To give students the opportunity to exercise their expertise on strategic and current projects.
- To allow them to discover the ecosystem of start-ups and innovations in health care while trying to instill in them an appetite for entrepreneurship.
- To take advantage of the project to highlight some topics less addressed during the year -supply chain and logistical organization in health care in particular.
For Lomig, Experience Lab Manager at AstraZeneca, the addition of the MsM students represented a real added value to help the entrepreneurs solve certain important problems. Allowing them to move forward quickly, thanks to the fresh perspective and expertise of the program students.
The system set up to make students and start-ups work together
To meet their ambitions, the AstraZeneca and MsM groups set up a collaborative program spanning seven weeks. 70 students provided their valuable input to the 10 selected start-ups between January 29 and March 10, 2021.
Ambitious solutions were then proposed to the students. Flowlity, for example, is an AI program dedicated to the forecasting and logistic planning of the vaccination campaign, for which the MsM students were asked to organize the implementation strategy on the national territory.
At the same time, Schoolab provided advice and expertise through an online coaching program that covered the fundamentals of design thinking and key steps to launching a successful project. Students were able to accompany real-life entrepreneurial projects while discovering new methodologies and tools in the field.
Objectives fully met for each of the stakeholders
Nicolas Baudelot, a co-founder of Medalib, confided in us that he was surprised by the motivation of the students and by the work produced in such a short time.
Naomie Woumeni, an MsM student, was particularly proud to have been able to contribute significantly to an innovative project. She told us that 80% of her group’s recommendations were retained by the company and Clément–founder of the start-up to which she contributed–has already implemented several of their recommendations with all his teams.
The average satisfaction of MsM students at the end of the program was 7.6/10.
Schoolab’s assistance allowed them to discover new methods and innovative approaches to solving big issues.
Lessons to remember for a successful collaboration of this type
The importance of framing and monitoring projects
The implementation of this program has reminded everyone of the importance of getting the process right.
When operating this type of program, it is important to :
- Fostering a communicative dynamic by organizing various events that bring together all the participants. This keeps the commitment and motivation of the actors intact – especially during a period of confinement when exchanges and relationships had to be managed at a distance.
- Define several milestones and meeting points throughout the program to ensure progress on projects.
- Ensuring continuous monitoring of progress of the collaborations: a progress review was organized every two weeks by a neutral person from outside the project with the 10 representatives of each group to highlight any difficulties or obstacles.
Diversity and collaboration, undeniable contributions for each of the actors
Each stakeholder had a role to play:
- Thanks to the participation of the start-ups, the students were able to actively and constructively immerse themselves in the ecosystem of entrepreneurship and innovation in healthcare.
- The students were able to bring a fresh perspective to the entrepreneurs and provide their knowledge and expertise to the competition winners.
- AstraZeneca and the MsM played a leading role in initiating the process in a joint and coordinated manner.
- Schoolab was thus able to better frame this collaboration and offer students new methodologies to better understand the healthcare start-up ecosystem.
Areas for improvement: a collaboration too short
After the summary meeting to reflect on this program, we all agreed that the collaboration project had been too short which:
- On one hand, the students arrived in an environment that they had to discover while collaborating on strategic and complex projects.
- On the other hand, most entrepreneurs found themselves managing teams that doubled in size overnight!
Some elements were highlighted that need to be kept in mind if this type of program is to be reproduced:
- Ensure that the ambitions and scope of the projects are adapted to the available time limit of the parties involved.
- Dedicate one person with an understanding of the needs and imperatives of all stakeholders. They will manage the project as a whole to align expectations and optimize the achievements of everyone’s objectives.
Article co-written by Marine Martinez, innovation project Manager – Schoolab; Frédéric Jallat, Scientific Director of the Advanced Master in Biopharmaceutical Management – ESCP (MsM); Lou Lacroix, Head of training and pedagogy – Schoolab; Lomig Unger, Experience Lab Manager – AstraZeneca France